Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies

Laura A McNay; Gretchen Arnoczy; Mary Martell; Polly Mock; Mary E Wright; Shelly Simpson; Mary Smolskis; Elizabeth S Higgs

doi:10.1016/j.vaccine.2021.09.008

Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies

Vaccine. 2021 Oct 8;39(42):6183-6185. doi: 10.1016/j.vaccine.2021.09.008. Epub 2021 Sep 14.

Authors

Laura A McNay¹, Gretchen Arnoczy², Mary Martell³, Polly Mock⁴, Mary E Wright⁵, Shelly Simpson⁶, Mary Smolskis⁵, Elizabeth S Higgs⁵

Affiliations

¹ National Institute for Allergy and Infectious Diseases, Bethesda, MD, United States. Electronic address: lmcnay@niaid.nih.gov.
² FirstHealth of the Carolinas, Pinehurst, NC, United States.
³ Cotton O'Neil Clinical Research Center, Topeka, KS, United States.
⁴ CHRISTUS Spohn Hospital, Corpus Christi, TX, United States.
⁵ National Institute for Allergy and Infectious Diseases, Bethesda, MD, United States.
⁶ Clinical Monitoring Research Program Directorate, Frederick National Laboratory, MD, United States.

Abstract

In the United States, clinical trials of COVID-19 vaccines and therapeutics quickly exhausted available clinical research capacity at large medical centers. The NIAID Division of Clinical Research tapped community hospitals to help fill the gap.

Keywords: Clinical research; Pandemic planning; Public health emergencies.

Published by Elsevier Ltd.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

COVID-19 Vaccines
COVID-19*
Emergencies*
Government
Hospitals, Community
Humans
Public Health
SARS-CoV-2
United States

Substances

COVID-19 Vaccines